Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Publication year range
1.
Braz. dent. sci ; 27(1): 1-12, 2024. ilus, tab
Article in English | LILACS, BBO - Dentistry | ID: biblio-1556414

ABSTRACT

Doenças periodontais e síndrome metabólica estão relacionadas a condições multifatoriais complicadas. No entanto, a relação ainda não é evidente. A insuficiência de estrogênio pode estar correlacionada a essa condição, possivelmente causada pela remoção dos ovários e infecção por Porphyromonas gingivalis (P. gingivalis). Este estudo teve como objetivo avaliar o efeito da disfunção ovariana causada pela ovariectomia e infecção por P. gingivalis no desenvolvimento da síndrome metabólica. Este foi um estudo experimental de laboratório utilizando ratos fêmeas da linhagem Sprague Dawley. Os modelos animais foram divididos em quatro grupos: controle, ovariectomia (OVX), ovariectomia-periodontite (OPG) e periodontite (PG). O objetivo de cada tratamento em cada grupo foi obter disfunção ovariana. O grupo OVX foi submetido à cirurgia de remoção dos ovários; no grupo PG foi realizada a indução de P. gingivalis; e no grupo OPG foi feita uma combinação de ovariectomia e indução de P. gingivalis. O sangue foi coletado e observado nos dias 0, 3, 7, 14, 21 e 28. A amostra de sangue foi examinada para ácido úrico, colesterol, glicose e estrogênio. Os dados coletados foram todos examinados estatisticamente. Todos os grupos de tratamento apresentaram peso corporal e observações bioquímicas sanguíneas significativamente maiores do que o grupo controle, exceto o colesterol total (p<0,05). Além disso, a maioria das variáveis apresentou uma correlação entre os grupos com o peso corporal e indicadores bioquímicos sanguíneos, exceto o nível de ácido úrico no sangue (R>0,5). A síndrome metabólica foi desencadeada pela disfunção ovariana causada pela infecção por P. gingivalis após a ovariectomia. Ambos apresentaram o mesmo risco. Mesmo a indução por P. gingivalis piorou a síndrome metabólica no grupo de modelos animais que foram submetidos à ovariectomia.(AU)


Periodontal diseases and metabolic syndrome are related to complicated multifactorial conditions. However, the relationship is not yet evident. Estrogen insufficiency might correlate to this condition, possibly caused by ovarian removal and Porphyromonas gingivalis (P. gingivalis) infection. This study aimed to evaluate the effect of ovarian dysfunction caused by ovariectomy and P. gingivalis infection to metabolic syndrome development. This study was an experimental laboratory study using female rats Sprague Dawley Strain. Animal models were divided into four groups: control, ovariectomy (OVX), ovariectomy-periodontitis (OPG), and periodontitis (PG). The purpose of every treatment in each group was to induce ovarian dysfunction. The OVX group was undertaken ovaries removal surgery. PG was performed P. gingivalis induction. Therefore OPG was a combination of ovariectomy and P. gingivalis induction. Blood was drawn and observed on days 0, 3, 7, 14, 21, and 28. The blood sample was examined for uric acid, cholesterol, glucose and estrogen. The collected data were all statistically examined. All treatment groups presented body weight and blood biochemical observation significantly higher than the control group, except total cholesterol (p<0.05). Moreover, most variables presented a correlation between groups to body weight and biochemical blood indicators, except blood uric acid level (R>0.5). The metabolic syndrome was triggered by ovarian dysfunction brought on by P. gingivalis infection after ovariectomy. They both took the same risk. Even P. gingivalis induction made metabolic syndrome in the group of animal models which underwent ovariectomy worse (AU)


Subject(s)
Animals , Rats , Ovariectomy , Metabolic Syndrome , Estrogens
2.
Front Endocrinol (Lausanne) ; 12: 656831, 2021.
Article in English | MEDLINE | ID: mdl-33953699

ABSTRACT

Background: The metabolic syndrome (MetS) is correlated with disorders of the reproductive system, such as the polycystic ovary syndrome (PCOS). While consumption of a diet rich in carbohydrates is linked to the development of MetS, it is still unclear if this diet leads to ovarian dysfunction and PCOS. Objectives: We investigated the influence of a high-sucrose diet (HSD) on the ovarian milieu of Wistar rats and studied the correlation between high consumption of sugary drinks and the prevalence of PCOS in women. Methods: Wistar rats were given a standard laboratory diet (CTR, 10% sucrose, n = 8) or HSD (HSD, 25% sucrose, n = 8) from postnatal day 21 to 120. Animals were evaluated weekly to calculate food intake, feed efficiency and weight gain. Both onset of puberty and estrous cycle were monitored. Metabolic serum biochemistry, organ morphometry and ovarian histology were performed upon euthanasia. In parallel, a fixed-effects multiple linear regression analysis was performed using data from Brazilian states (459 state-year observations) to test the correlation between the consumption of sugar-sweetened beverages (surrogate for HSD intake) and the prevalence of PCOS (surrogate for ovarian dysfunction). Results: HSD animals showed increased adipose tissue accumulation, hyperglycaemia and insulin resistance when compared to CTR. Interestingly HSD rats also entered puberty earlier than CTR. Moreover, ovaries from HSD animals had an increased number of atretic antral follicles and cystic follicles, which were correlated with the hypertrophy of periovarian adipocytes. Finally, there was a positive correlation between the intake of sugary drinks and prevalence of PCOS in women of reproductive age. Conclusions: HSD ingestion leads to ovarian dysfunction in rats and could be correlated with PCOS in women, suggesting these alterations could lead to public health issues. Therefore, we reinforce the deleterious impact of HSD to the ovarian system and suggest that the reduction of added sugars intake could be beneficial to ovarian health.


Subject(s)
Dietary Sucrose/toxicity , Estrous Cycle , Metabolic Syndrome/pathology , Ovary/pathology , Polycystic Ovary Syndrome/pathology , Sexual Maturation , Animals , Body Weight , Female , Metabolic Syndrome/chemically induced , Metabolic Syndrome/metabolism , Ovary/drug effects , Polycystic Ovary Syndrome/chemically induced , Polycystic Ovary Syndrome/metabolism , Rats , Rats, Wistar
3.
Article in Portuguese | LILACS | ID: lil-552657

ABSTRACT

A prevalência de disfunção ovariana é alta em mulheres com doença renal crônica e parece resultar da disfunção em diversos níveis do eixo hipotálamo-hipófise-ovariano (HHO). Estas pacientes costumam apresentar ciclos irregulares, amenorréia, atraso no desenvolvimento puberal e baixa estatura. No entanto, em pacientes transplantadas renais, há uma melhora da função do eixo HHO, incluindo a melhora da fertilidade. Por isso, a contracepção após o transplante é importante e deve ter uma abordagem especializada. Ao prescrever um método contraceptivo, deve-se levar em conta a vulnerabilidade do órgão transplantado, os efeitos adversos, as interações medicamentosas, seus potenciais benefícios e malefícios e a condição clínica da paciente. O objetivo dessa revisão foi avaliar o eixo HHO das pacientes com doença renal crônica (DRC) ou transplante renal, bem como as peculiaridades da contracepção, uso de drogas e avaliação do colo uterino nessas pacientes.


The prevalence of ovarian dysfunction is high in women with CKD and seems to result from dysfunction at several levels along hypothalamic-pituitary-ovarian (HPO) axis. This situation results in menstrual disturbances or even amenorrhea, late puberty, and low stature. On the other hand, kidney transplantation can improve these abnormalities and also increase fertility. The contraception after transplantation is important and must have a specialized approach. When prescribing a contraceptive method, the vulnerability of the graft, side effects, drug interaction and clinical condition of the patient must be evaluated. The objective of this review was to evaluate the HPO axis of patients with chronic kidney disease (CKD) or kidney transplantation and the peculiarities of contraception, drug and cervical assessment in these patients.


Subject(s)
Humans , Female , Adolescent , Adult , Contraception , Contraception/psychology , Contraception/trends , Renal Insufficiency, Chronic/complications , Renal Insufficiency, Chronic/diagnosis , Renal Insufficiency, Chronic/psychology , Kidney Transplantation , Kidney Transplantation/psychology , Kidney Transplantation/rehabilitation , Ovarian Function Tests , Prevalence
SELECTION OF CITATIONS
SEARCH DETAIL